Company profile

Ticker
PHOT
Exchange
CEO
Marco Hegyi
Employees
Incorporated
Location
Fiscal year end
Former names
CATALYST LIGHTING GROUP INC, PHOTOTRON HOLDINGS, INC., WENTWORTH III INC
SEC CIK
IRS number
900821083

PHOT stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 Aug 20
30 Sep 20
31 Dec 20

News

Quarter (USD) Jun 20 Mar 20 Sep 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Growlife earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
16 Apr 20 Kozik Thom Common Stock Grant Aquire A No 0.295 20,000 5.9K 93,907
16 Apr 20 McLain Katherine Common Stock Grant Aquire A No 0.295 20,000 5.9K 106,675
0.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2 0 NEW
Opened positions 2 0 NEW
Closed positions 0 6 EXIT
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 251K 0 NEW
Total shares 15.01K 0 NEW
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Elmwood Wealth Management 15K $251K NEW
IFP Advisors 14 $0 NEW
Largest transactions
Shares Bought/sold Change
Elmwood Wealth Management 15K +15K NEW
IFP Advisors 14 +14 NEW

Financial report summary

?
Competition
United CannabisHydrofarm
Risks
  • Risks Associated with EZ-CLONE Enterprises, Inc.
  • We have been involved in Legal Proceedings.
  • Our proposed business is dependent on laws pertaining to the marijuana industry.
  • The marijuana industry faces strong opposition.
  • Marijuana remains illegal under Federal law.
  • Raising additional capital to implement our business plan and pay our debts will cause dilution to our existing stockholders, require us to restructure our operations, and divest all or a portion of our business.
  • Closing of bank and merchant processing accounts could have a material adverse effect on our business, financial condition and/or results of operations.
  • Federal regulation and enforcement may adversely affect the implementation of medical marijuana laws and regulations may negatively impact our revenues and profits.
  • Our history of net losses has raised substantial doubt regarding our ability to continue as a going concern. If we do not continue as a going concern, investors could lose their entire investment.
  • We have a history of operating losses and there can be no assurance that we can again achieve or maintain profitability.
  • We are subject to corporate governance and internal control reporting requirements, and our costs related to compliance with, or our failure to comply with existing and future requirements, could adversely affect our business.
  • Our inability or failure to effectively manage our growth could harm our business and materially and adversely affect our operating results and financial condition.
  • If we do not successfully generate additional products and services, or if such products and services are developed but not successfully commercialized, we could lose revenue opportunities.
  • Our future success depends on our ability to grow and expand our customer base. Our failure to achieve such growth or expansion could materially harm our business.
  • Our inability to effectively protect our intellectual property would adversely affect our ability to compete effectively, our revenue, our financial condition and our results of operations.
  • Our industry is highly competitive and we have less capital and resources than many of our competitors, which may give them an advantage in developing and marketing products similar to ours or make our products obsolete.
  • Transfers of our securities may be restricted by virtue of state securities “blue sky” laws, which prohibit trading absent compliance with individual state laws. These restrictions may make it difficult or impossible to sell shares in those states.
  • We are dependent on key personnel.
  • Chicago Venture, Illiad and Odyssey could have significant influence over matters submitted to stockholders for approval.
  • Trading in our stock is limited by the SEC’s penny stock regulations.
  • FINRA sales practice requirements may also limit a shareholder’s ability to buy and sell our stock.
  • The market price of our common stock may be volatile.
  • The sale of a significant number of our shares of common stock could depress the price of our common stock.
  • Some of our convertible debentures and warrants may require adjustment in the conversion price.
  • We do not anticipate paying any cash dividends on our capital stock in the foreseeable future.
  • Anti-takeover provisions may limit the ability of another party to acquire our company, which could cause our stock price to decline.
  • We may issue preferred stock that could have rights that are preferential to the rights of common stock that could discourage potentially beneficially transactions to our common shareholders.
  • If the company were to dissolve or wind-up, holders of our common stock may not receive a liquidation preference.
Management Discussion
  • Net revenue for the three months ended June 30, 2020 decreased by $351,000 to $1,850,000 from $2,201,000 for the three months ended June 30, 2019. Our June 30, 2020 quarter one was impacted by the Covid-19 pandemic. However, we have a sales order backlog of $1,026,000 into the third quarter. The commercial revenue for the three months ended June 30, 2020 was $641,000 as compared to $1,278,000 for the three months ended June 30, 2019. The EZ-CLONE revenue for the three months ended June 30, 2020 was $1,209,000 as compared to $917,000 for the three months ended June 30, 2019.
  • Cost of sales for the three months ended June 30, 2020 decreased by $403,000 to $1,122,000 from $1,525,000 for the three months ended June 30, 2019. Decrease was related to lower revenue, our quarter one was impacted by the Covid-19 pandemic.
  • Gross profit was $728,000 for the three months ended June 30, 2020 as compared to a gross profit of $676,000 for the three months ended June 30, 2019. The gross profit percentage was 39.3% for the three months ended June 30, 2020 as compared to 30.7% for the three months ended June 30, 2019. The increase in gross profit margin related to favorable product mix related to the acquisition of EZ-CLONE on October 15, 2018. EZ-CLONE reported a gross profit percentage of 50.6% during the three months ended June 30, 2020.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: antidilutive, beverage, CPG, deadline, deferral, disappoint, EIDL, fact, fall, FDA, forfeited, forgiven, gather, hit, Illiad, infected, Injury, Journal, noncash, outdoor, partner, penalty, postponed, prepayment, prospective, push, reclassification, repaid, restaurant, rippling, shut, targeted, temporarily, upended, wasting
Removed: added, agricultural, agriculture, ahead, appointed, attending, avoid, begin, billion, booming, burned, Clear, Coco, commercially, compound, conservative, consumed, content, core, creating, CRIB, crop, DEA, deal, debut, dedicate, device, educate, Emerald, environmental, exploding, extremely, facility, favorite, feminized, focusing, foresight, Gel, gender, genetically, goal, healthy, heard, Hobbyist, hope, imaging, increasing, innovation, innovator, intensive, launching, LED, legalization, light, lot, machine, maintenance, maximize, mission, mobile, modified, mother, nation, nationwide, necessity, planted, producing, project, put, ramping, ready, reiterate, renewed, resource, revolutionary, Rez, rich, rooting, scalable, seed, shocked, simply, simultaneously, sizable, size, soil, solution, spectral, stay, stick, strategically, struck, supplier, switch, switching, tabletop, testament, THC, timeframe, traditional, trajectory, trimming, understand, understated, unique, viability, word